Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 11/20 | 0.48 |
| ▸ | RAB9A | P51151 | 10/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KHK | P50053 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.40 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12420946 | 0.93 | KHK (0.44) | NPC1RAB9AKMT2AMEN1KHK | |
| SCHEMBL12420296 | 0.93 | NPC1 (0.49) | NPC1RAB9ASMN1; SMN2LMNAKMT2A | |
| SCHEMBL2296240 | 0.91 | NPC1 (0.46) | NPC1RAB9ASMN1; SMN2LMNAKMT2A | |
| SCHEMBL12420302 | 0.90 | NPC1 (0.44) | NPC1RAB9ASMN1; SMN2LMNAKMT2A | |
| SCHEMBL2299091 | 0.89 | NPC1 (0.44) | NPC1RAB9ASMN1; SMN2LMNAKMT2A | |
| SCHEMBL12420209 | 0.85 | F10 (0.44) | NPC1RAB9ASMN1; SMN2LMNAKHK | |
| SCHEMBL12420237 | 0.85 | RAB9A (0.51) | NPC1RAB9AKMT2AMEN1 | |
| SCHEMBL12421963 | 0.84 | NPC1 (0.52) | NPC1RAB9ASMN1; SMN2LMNAKMT2A | |
| SCHEMBL2296401 | 0.84 | ITGB3 (0.45) | NPC1RAB9ASMN1; SMN2KMT2AMEN1 | |
| SCHEMBL2297559 | 0.84 | NPC1 (0.47) | NPC1RAB9ASMN1; SMN2LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8003806-B2 | Integrin antagonists useful as anticancer agents | OSI Pharmaceuticals, LLC (US) | 2011-08-23 | — | — | US | disclosed |